News

The leasing and finance program provides a non-recourse financial solution for PURE EP™ to improve purchase flexibility for U.S. hospitals.

3 to 5 April in Copenhagen, Denmark and online

FDA-cleared artificial intelligence (AI) algorithms that detect leading indicators of heart disease are now available to healthcare professionals in the all-new Eko App

Stereotaxis robotic technology now in use in 25 countries St. Louis, March 25, 2021 — Stereotaxis, offering innovative robotic technologies for the treatment of cardiac arrhythmias, announced that Poland’s National Institute of Cardiology,...

Stereotaxis robotic technology now in use in 25 countries

Great Debates & Updates in Electrophysiology is a unique, debate-style conference covering the most controversial topics in electrophysiology. It is offered complimentary for clinicians. Don’t miss the first in this quarterly virtual series,...

Physicians accessing GE Healthcare’s MUSE, a cardiac management system that connects to and integrates into the electronic medical record (EMR), can now view and interpret in MUSE ECGs taken by patients using AliveCor’s KardiaMobile 6L...

Avive Solutions, Inc. announced that it closed a $22 million Series A round of financing co-led by Questa Capital, Catalyst Health Ventures and repeat investor Laerdal Million Lives Fund.

Clearance paves the way for increased use of advanced EP technology

Annual List of Patient Safety Concerns Dominated by Longstanding Stressors on Healthcare Workers Exacerbated by Pandemic